Answers are grounded in this paper and cite their sources.
In April 2019, the American Academy of Dermatology (AAD) and the National Psoriasis Foundation (NPF) released a set of guidelines regarding the management of psoriasis with a focus on its extracutaneous manifestations-comorbidities, mental health, psychosocial wellness, and quality of life (QOL). These guidelines provide the most up-to-date evidence on the screening and treatment recommendations for these disease comorbidities. The purpose of this review is to present the recommendations in a form that can be easily applied in clinical practice.
No takes yet. Share an insight, caveat, or question.
Vipawee S. Chat (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: